Humana Inc. (NYSE:HUM) Shares Bought by High Ground Investment Management LLP

High Ground Investment Management LLP increased its holdings in shares of Humana Inc. (NYSE:HUM) by 43.5% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 424,403 shares of the insurance provider’s stock after acquiring an additional 128,636 shares during the quarter. Humana makes up 33.4% of High Ground Investment Management LLP’s portfolio, making the stock its biggest position. High Ground Investment Management LLP’s holdings in Humana were worth $107,675,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. New Age Alpha Advisors LLC bought a new position in Humana in the fourth quarter valued at approximately $2,960,000. Norges Bank acquired a new stake in shares of Humana during the fourth quarter worth $416,202,000. NEOS Investment Management LLC lifted its position in Humana by 27.9% in the 4th quarter. NEOS Investment Management LLC now owns 5,697 shares of the insurance provider’s stock valued at $1,445,000 after acquiring an additional 1,241 shares in the last quarter. UniSuper Management Pty Ltd boosted its stake in Humana by 32.8% in the 4th quarter. UniSuper Management Pty Ltd now owns 11,227 shares of the insurance provider’s stock worth $2,848,000 after purchasing an additional 2,770 shares during the period. Finally, Artisan Partners Limited Partnership increased its holdings in Humana by 83.4% during the 4th quarter. Artisan Partners Limited Partnership now owns 673,715 shares of the insurance provider’s stock worth $170,928,000 after purchasing an additional 306,433 shares in the last quarter. 92.38% of the stock is currently owned by institutional investors.

Humana Stock Performance

Shares of HUM stock opened at $270.04 on Friday. Humana Inc. has a 52 week low of $213.31 and a 52 week high of $406.46. The company has a market capitalization of $32.59 billion, a price-to-earnings ratio of 27.14, a PEG ratio of 2.05 and a beta of 0.57. The company has a 50-day simple moving average of $270.51 and a 200 day simple moving average of $274.93. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76.

Humana (NYSE:HUM) last issued its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. On average, sell-side analysts predict that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be given a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.31%. The ex-dividend date is Friday, March 28th. Humana’s payout ratio is currently 35.58%.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on HUM shares. Barclays boosted their price target on Humana from $255.00 to $270.00 and gave the company an “equal weight” rating in a report on Thursday, February 13th. Piper Sandler boosted their target price on Humana from $270.00 to $288.00 and gave the company a “neutral” rating in a research note on Wednesday, January 15th. Truist Financial raised their price target on shares of Humana from $260.00 to $290.00 and gave the stock a “hold” rating in a research note on Monday, January 6th. Royal Bank of Canada reissued an “outperform” rating and issued a $283.00 price objective on shares of Humana in a research report on Wednesday, February 12th. Finally, Morgan Stanley decreased their target price on shares of Humana from $301.00 to $285.00 and set an “equal weight” rating for the company in a research report on Wednesday, February 12th. Eighteen equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. According to MarketBeat.com, Humana presently has an average rating of “Hold” and an average price target of $285.68.

Insider Activity at Humana

In other Humana news, insider Timothy S. Huval sold 3,703 shares of the stock in a transaction dated Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total transaction of $948,930.78. Following the sale, the insider now directly owns 8,181 shares in the company, valued at $2,096,463.06. This represents a 31.16 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 0.37% of the stock is owned by insiders.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.